By Fineline Cube The National Health Commission (NHC) of the People’s Republic of China issued the Notice on Strengthening the Management of Continuous Medication Use among Residents, establishing a scientific and standardized management mechanism designed to improve healthcare quality and mitigate medication-related risks.
Policy Framework & Objectives
| Component | Detail |
|---|---|
| Issuing Authority | National Health Commission of China |
| Policy Document | Notice on Strengthening the Management of Continuous Medication Use among Residents |
| Announcement Date | 10 Jul 2026 |
| Primary Objective | Establish scientific, standardized continuous medication management mechanism |
| Target Population | All Chinese residents engaged in ongoing medication regimens |
| Implementation Scope | Nationwide with regional customization |
This comprehensive policy framework represents a significant advancement in China’s healthcare system modernization, addressing critical gaps in medication safety and continuity of care.
Continuous Medication Management Definition
- Core Concept: Systematic recording, analyzing, and application of continuous medication information generated during medical treatment and medication use
- Primary Goals:
- Safeguard basic medical needs of the public
- Improve quality of healthcare services
- Mitigate medication-related risks
- Scope: Covers all prescription and over-the-counter medications used on an ongoing basis
- Data Integration: Links clinical, pharmacy, and patient-reported medication information
The initiative recognizes that effective medication management is fundamental to achieving optimal health outcomes, particularly for patients with chronic conditions requiring long-term drug therapy.
Three-Pillar Implementation Strategy
Multi-tiered Management Mechanism
- Structure: Hierarchical management system spanning national, provincial, municipal, and institutional levels
- Regional Expansion: Enhanced management functions for continuous medication use within each administrative region
- Coordination: Clear delineation of responsibilities across different healthcare delivery levels
- Oversight: Standardized monitoring and evaluation protocols
Medication Information Co-construction and Sharing
- Data Infrastructure: Integrated electronic health record systems with medication tracking capabilities
- Clinical Feedback Loop: Establishment of systematic clinical medication feedback mechanisms
- Interoperability: Seamless data exchange between hospitals, clinics, pharmacies, and public health authorities
- Privacy Protection: Robust data security and patient confidentiality safeguards
Standardized Workflow Management
- Process Standardization: Uniform protocols for medication prescribing, dispensing, monitoring, and review
- Quality Control: Evidence-based guidelines for appropriate medication use
- Risk Mitigation: Proactive identification and management of potential medication errors and adverse events
- Performance Metrics: Measurable outcomes for continuous quality improvement
Healthcare System Impact
| Aspect | Current Challenge | NHC Initiative Impact |
|---|---|---|
| Medication Safety | Fragmented information systems | Integrated medication tracking |
| Care Coordination | Poor communication between providers | Standardized information sharing |
| Chronic Disease Management | Inconsistent medication adherence | Structured follow-up protocols |
| Healthcare Quality | Variable medication practices | Evidence-based standardization |
| Public Health Surveillance | Limited medication utilization data | Comprehensive monitoring system |
China’s aging population and rising burden of chronic diseases make effective medication management increasingly critical. An estimated 190 million Chinese adults have hypertension, while diabetes affects over 140 million people, creating substantial demand for coordinated medication management.
Strategic Implications
- Healthcare Modernization: Aligns with China’s broader healthcare system reform objectives
- Digital Health Integration: Leverages existing health information technology infrastructure investments
- Patient-Centered Care: Shifts focus toward comprehensive, longitudinal medication management
- Cost Containment: Potential to reduce hospital admissions related to medication errors and non-adherence
- Global Leadership: Positions China as innovator in population-level medication safety initiatives
The policy demonstrates China’s commitment to addressing medication safety as a fundamental component of healthcare quality improvement.
Implementation Timeline & Next Steps
- Phase 1 (2026): Policy dissemination and regional implementation planning
- Phase 2 (2027): Pilot programs in selected provinces and major cities
- Phase 3 (2028): Nationwide rollout with standardized metrics and reporting requirements
- Ongoing: Continuous evaluation and refinement based on implementation experience
Provincial health commissions will develop detailed implementation guidelines tailored to local healthcare system characteristics while maintaining national standards.
Stakeholder Engagement
- Healthcare Providers: Hospitals, clinics, and individual practitioners responsible for implementation
- Pharmaceutical Sector: Pharmacies and pharmaceutical companies supporting medication information systems
- Technology Partners: Health IT vendors providing infrastructure and analytics capabilities
- Academic Institutions: Research organizations contributing evidence base and evaluation expertise
- Patient Advocacy Groups: Ensuring patient perspectives inform implementation approaches
Forward‑Looking Statements
This brief contains forward-looking statements regarding policy implementation and healthcare system improvements. Actual outcomes may differ due to implementation challenges, resource constraints, and evolving healthcare priorities.-Fineline Info & Tech